Aug 2026· Neurobiology of Aging· Vol 168, pp.
147-158
· 0 citations· 58 references
Medicine
TL;DR
Trans transcranial magnetic stimulation with electromyography is used to investigate mechanisms of motor cortical excitability in biomarker-positive early-AD participants and 72 cognitively unimpaired age-matched adults and shows that early-AD participants have increased motor cortical excitability, related to cognition.
Abstract
Recent studies suggest that cortical hyperexcitability in Alzheimer's disease (AD) may accelerate disease progression. However, the field lacks validated non-invasive methods to assay excitability in humans. In this study we used transcranial magnetic stimulation with electromyography to investigate mechanisms of motor cortical excitability in 63 biomarker-positive early-AD (ranging from mild cognitive impairment to mild dementia) participants and 72 cognitively unimpaired age-matched adults (CU). Single-pulse stimulation was applied to motor cortex to record resting motor thresholds (rMT) and motor-evoked potentials. An Input-Output curve was generated by delivering 10 pulses each at eight different intensities of maximum stimulator output (%MSO). Linear models or equivalent non-parametric tests 1) compared excitability metrics between groups, 2) tested correlations with cognition (mini-mental state exam, MMSE; Alzheimer's disease assessment scale-cognitive, ADAS-Cog), and 3) tested the impact of APOE4. Results show that early-AD participants have increased motor cortical excitability than CU, with lower rMT (p < 0.001), lower Input-Output curve Inflection Point (p = 0.007), and higher Dynamic Range (p = 0.035). An analysis of the Input-Output curve adjusting for rMT showed larger responses in AD specifically in the 135-150% rMT range (p = 0.023). In AD, higher excitability was related to worse cognition (rMT: MMSE p = 0.008, Inflection Point: MMSE p = 0.030 and ADAS-Cog p = 0.041). There was no relationship between APOE4 and excitability. In conclusion, AD participants have increased motor cortical excitability, related to cognition. This is evident both at lower and higher stimulation intensities. TMS may provide a useful measure of target engagement for therapies aimed at preserving cognition or slowing decline in early-AD.
It is concluded that frontal cognitive control systems play a causal role in modulating movement in Parkinson’s disease and suggest that targeting these systems with non-invasive interventions may enhance motor function.
Rupsha Panda, James A. Brissenden, Teresa Scerbak et al.· bioRxiv· 0 citations
Progressive, age-dependent remodeling of motor cortex somatotopic remodeling is demonstrated in 5XFAD mice, characterized by early expansion of specific simple movement cortical sites followed by deterioration of both complex and simple motor cortical maps as disease advances.
SE Moss, Cassandra C. Wolsh, Rmii Brown et al.· bioRxiv· 0 citations
Although MEP shows promise as a biomarker for cognitive impairment assessment, longitudinal validation is needed to confirm its predictive utility, as the excitability of the unaffected motor cortex progressively declines with worsening cognition.
Zhipeng Yan, Hao Luo, Bilian Guo· Annals of Human Biology· 0 citations
Findings reveal that PPC-targeted, full-frequency time-varying network decoupling is a core neuropathological mechanism in PD-MCI, providing a foundation for early diagnosis and targeted neuromodulation.
Qi Zhu, Guangying Pei, Meng-Xuan Hu et al.· Journal of Physics, Conferen...· 0 citations
Different diagnostic group-specific patterns in the olfaction-brain structure relationship are highlighted, with implications for understanding early pathological aging and neurodegeneration.
P. P. Giriprakash, J. Caldwell, R. L. Doty et al.· Journal of Neurological Scie...· 0 citations
Ultra-high-field MRS preliminary evidence for altered resting M1 GABAergic neurochemistry in mild-to-moderate PD supports the utility of 7T MRS for probing motor-cortical neurochemistry in PD.
Ning Wei, Dong-Ning Su, Zhe Zhang et al.· Parkinsonism & Related Disor...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.